Federal Xarelto Lawsuits Progress, As Bernstein Liebhard LLP Comments on Issuance of Most Recent Pretrial Order

Share Article

The Firm is representing numerous plaintiffs whose Xarelto lawsuits are currently pending in federal court.

Free Case Review
The Order indicates that the Court has established standards and procedures pertaining to the litigation’s Common Benefit Fund, which will apply to any attorney representing a Xarelto plaintiff in the Eastern District of Louisiana.

The federal litigation established for Xarelto lawsuits (http://www.xareltolawsuit2015.com/) continues to move forward in the U.S. District Court, Eastern District of Louisiana, Bernstein Liebhard LLP reports. According to court records, the proceeding issued its eighth Pretrial Order on February 13, 2014. (In Re: Xarelto Products Liability Litigation, No. 2592)

“The Order indicates that the Court has established standards and procedures pertaining to the litigation’s Common Benefit Fund, which will apply to any attorney representing a Xarelto plaintiff in the Eastern District of Louisiana, as well as any who represent such a plaintiff in state court who benefits from work performed in the federal multidistrict litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently representing numerous plaintiffs who have Xarelto lawsuits pending in the federal proceeding, and continues to offer free, no-obligation legal reviews to individuals who allegedly suffered serious injuries from the blood thinner, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.

Xarelto Litigation
According to court records,the federal Xarelto litigation was established by an Order of the U.S. Judicial Panel on Multidistrict Litigation in December 2014. Initially, just 21 actions filed on behalf of individuals who allegedly experienced uncontrollable internal bleeding and other complications due to their use of Xarelto were transferred to the proceeding. Court documents now indicate that at least 220 claims had been filed in the proceeding as of February 17, 2015. According to Bernstein Liebhard LLP, multidistrict litigations, such as the one established for Xarelto lawsuits, are created to allow a large number of cases involving common questions of fact to undergo coordinated pretrial proceedings. This allows the lawsuits to move more efficiently through the court system by avoiding duplicative discovery and inconsistent court rulings across the docket. All federally-filed claims involving the blood thinner are now subject to transfer to the consolidated proceeding.

All of the Xarelto lawsuits pending in the Eastern District of Louisiana similarly allege that use of the blood thinning medication caused patients to experience life-threatening complications, including uncontrollable bleeding, hemorrhagic strokes, deep vein thrombosis and pulmonary embolism. Among other things, plaintiffs charge that the manufacturers of the drug downplayed the risk of serious bleeding in promotional materials for Xarelto, and wrongly positioned it as a superior alternative to warfarin, a blood thinner that has been in use for decades. The lawsuits point out that while hemorrhaging associated with warfarin can be stopped via the administration of vitamin K, there is currently no approved antidote to reverse Xarelto bleeding.

Xarelto patients who allegedly experienced life-threatening episodes of internal bleeding and other complications related to its use may be entitled to compensation for medical bills, lost wages, pain and suffering and more. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website